Working with WHO to resolve issues: Bharat Biotech on Covaxin delay

“As a responsible manufacturer with past approvals for our other vaccines, we do not find it appropriate to speculate or comment on the regulatory approval process & its timelines,” it said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kTndot
via IFTTT